Dr Kate Hutchence
School of Medicine and Population Health
Research Assistant
+44 114 222 0761
Full contact details
School of Medicine and Population Health
2.15, CTRU
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
- Profile
-
I joined CTRU as a Research Assistant in March 2022 and I am currently working on two trials: MissionEB (mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa), and MAGIC (Melatonin for Anxiety prior to General anaesthesia In Children).
Prior to coming to ScHARR I worked in frontline health in the NHS, treating patients with a variety of pathologies in the brain using Gamma Knife Radiosurgery. I originally trained in Zoology and completed a PhD in the field of Evolutionary Biology. I worked as a research scientist examining co-evolution and host-parasite interactions in insects prior to a career transition to working in human health.
- Qualifications
-
- MPH | MASTERS IN PUBLIC HEALTH University of Sheffield | Distinction | Completed Oct 2021, Graduation 2022
- PgDip | RADIOTHERAPY AND ONCOLOGY IN PRACTICE Sheffield Hallam University | Graduated November 2016
- PhD | THE EVOLUTIONARY ECOLOGY OF HOST PARASITE INTERACTIONS The University of Liverpool | Graduated July 2011
- MBiolSci | ZOOLOGY University of Sheffield | 2:1 honors | Graduated July 2004
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension. BMJ Open, 15(5). View this article in WRRO
- The MAGIC trial: a pragmatic, multicentre, parallel, noninferiority, randomised trial of melatonin versus midazolam in the premedication of anxious children attending for elective surgery under general anaesthesia. British Journal of Anaesthesia. View this article in WRRO
- Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension. BMJ Open, 15(5). View this article in WRRO